Skin Diseases  >>  Decadron (dexamethasone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Decadron (dexamethasone) / Merck (MSD)
NCT01825265: Phase II: RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

Withdrawn
2
0
US
Docetaxel, Taxotere, RAD001, Dexamethasone, Decadron
M.D. Anderson Cancer Center, Novartis Pharmaceuticals
Breast Cancer
04/12
04/12
NCT00832338: Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Terminated
2
23
US
Docetaxel with Cytoxan, Docetaxel, Cytoxan, Dexamethasone, Decadron
Emory University, Sanofi
Breast Neoplasms, Breast Cancer, Cancer of the Breast
10/15
10/15
NCT01332630: TPI 287 in Breast Cancer Metastatic to the Brain

Completed
2
24
US
TPI 287, Dexamethasone, Decadron, Benadryl, Diphenhydramine, Ranitidine, Zantac, Ranitidine hydrochloride
M.D. Anderson Cancer Center, Cortice Biosciences, Inc.
Breast Cancer
04/17
04/17

Download Options